These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 22402069)

  • 21. Sustained improvement of dyslipidaemia in HAART-treated patients replacing stavudine with tenofovir.
    Llibre JM; Domingo P; Palacios R; Santos J; Pérez-Elías MJ; Sánchez-de la Rosa R; Miralles C; Antela A; Moreno S;
    AIDS; 2006 Jun; 20(10):1407-14. PubMed ID: 16791015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe dyslipidemia and immune activation in HIV patients with dysglycemia.
    Jin C; Ji S; Xie T; Höxtermann S; Fuchs W; Lu X; Wu H; Cheng L; Skaletz-Rorowski A; Brockmeyer NH; Wu N
    HIV Clin Trials; 2016 Sep; 17(5):189-96. PubMed ID: 27409415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CENTRAL RETINAL ARTERY OCCLUSION IN A YOUNG HIV-INFECTED PATIENT ON HIGHLY ACTIVE ANTIRETROVIRAL THERAPY.
    Lenci LT; Chin EK; Almeida DR
    Retin Cases Brief Rep; 2017 Spring; 11(2):160-162. PubMed ID: 27111556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Highly active antiretroviral therapy-related hepatotoxicity in human immunodeficiency virus and hepatitis C virus co-infected patients with advanced liver fibrosis in Taiwan.
    Chou CC; Tsai HC; Wu KS; Sy CL; Chen JK; Chen YS; Lee SS
    J Microbiol Immunol Infect; 2016 Aug; 49(4):546-53. PubMed ID: 25440980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy.
    Santoro-Lopes G; de Pinho AM; Harrison LH; Schechter M
    Clin Infect Dis; 2002 Feb; 34(4):543-6. PubMed ID: 11797184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum levels of IgG antibodies against oxidized LDL and atherogenic indices in HIV-1-infected patients treated with protease inhibitors.
    da Cunha J; Ferreira Maselli LM; Treitinger A; Monteiro AM; Gidlund M; Maranhão RC; Spada C; Bydlowski SP
    Clin Chem Lab Med; 2013 Feb; 51(2):371-8. PubMed ID: 23241595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin resistance and lipid profiles in HIV-infected Thai children receiving lopinavir/ritonavir-based highly active antiretroviral therapy.
    Dejkhamron P; Unachak K; Aurpibul L; Sirisanthana V
    J Pediatr Endocrinol Metab; 2014 May; 27(5-6):403-12. PubMed ID: 24259240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group.
    Dubé MP; Stein JH; Aberg JA; Fichtenbaum CJ; Gerber JG; Tashima KT; Henry WK; Currier JS; Sprecher D; Glesby MJ; ;
    Clin Infect Dis; 2003 Sep; 37(5):613-27. PubMed ID: 12942391
    [No Abstract]   [Full Text] [Related]  

  • 29. Polymorphisms in LPL, CETP, and HL protect HIV-infected patients from atherogenic dyslipidemia in an allele-dose-dependent manner.
    Guardiola M; Echeverria P; González M; Vallvé JC; Puig J; Clotet B; Ribalta J; Negredo E
    AIDS Res Hum Retroviruses; 2015 Sep; 31(9):882-8. PubMed ID: 26101956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Metabolic and cardiovascular effects of combined antiretroviral therapy in patients with HIV infection. Systematic review of literature].
    Casaretti L; Paolillo S; Formisano R; Bologna A; Mattiello G; Conte S; Petraglia L; Lo ludice F; Fabiani I; Cirillo AP; Vitagliano A; Gambardella F; della Ratta GL; Filardi PP
    Monaldi Arch Chest Dis; 2011 Dec; 76(4):175-82. PubMed ID: 22567733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endocrine and metabolic abnormalities among HIV-infected patients: a current review.
    Kibirige D; Ssekitoleko R
    Int J STD AIDS; 2013 Aug; 24(8):603-11. PubMed ID: 23970578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Highly active antiretroviral therapy-associated metabolic syndrome and cardiovascular risk.
    Barbaro G; Barbarini G
    Chemotherapy; 2006; 52(4):161-5. PubMed ID: 16675900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Metabolic abnormalities, lipodystrophy and cardiovascular risk in HIV-infected patients].
    Leclercq P; Blanc M
    Rev Prat; 2006 May; 56(9):987-94. PubMed ID: 16775979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reproduction and fertility in human immunodeficiency virus type-1 infection.
    van Leeuwen E; Prins JM; Jurriaans S; Boer K; Reiss P; Repping S; van der Veen F
    Hum Reprod Update; 2007; 13(2):197-206. PubMed ID: 17099206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Lipodystrophy syndrome in HIV-infected patients. Clinical and diagnostic features].
    Streinu-Cercel A; Ion DA; Chivu LI; Chivu RD
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(3):521-5. PubMed ID: 17571539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Highly Active Antiretroviral Therapy on paediatric Human Immunodeficiency Virus-associated left ventricular dysfunction within the Johannesburg teaching hospital complex.
    Pepeta L; Cilliers AM
    Cardiol Young; 2012 Oct; 22(5):564-73. PubMed ID: 22325487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selected metabolic and morphologic complications associated with highly active antiretroviral therapy.
    Smith KY
    J Infect Dis; 2002 May; 185 Suppl 2():S123-7. PubMed ID: 12001033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dilated cardiomyopathy in an adult human immunodeficiency virus type 1-positive patient treated with a zidovudine-containing antiretroviral regimen.
    Tanuma J; Ishizaki A; Gatanaga H; Kikuchi Y; Kimura S; Hiroe M; Oka S
    Clin Infect Dis; 2003 Oct; 37(7):e109-11. PubMed ID: 13130421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of Spirulina platensis supplementation on lipid profile in HIV-infected antiretroviral naïve patients in Yaounde-Cameroon: a randomized trial study.
    Ngo-Matip ME; Pieme CA; Azabji-Kenfack M; Biapa PC; Germaine N; Heike E; Moukette BM; Emmanuel K; Philippe S; Mbofung CM; Ngogang JY
    Lipids Health Dis; 2014 Dec; 13():191. PubMed ID: 25496727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of highly active antiretroviral therapy with increased arterial stiffness in patients infected with human immunodeficiency virus.
    Lekakis J; Ikonomidis I; Palios J; Tsiodras S; Karatzis E; Poulakou G; Rallidis L; Antoniadou A; Panagopoulos P; Papadopoulos A; Triantafyllidi H; Giamarellou H; Kremastinos DT
    Am J Hypertens; 2009 Aug; 22(8):828-34. PubMed ID: 19556973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.